Hugo Davila

Hugo Davila
A Board-certified urologist and Clinical Assistant Professor at Florida State University, College of Medicine, Dr. Hugo Davila completed his surgery and urology training at University of South Florida and Moffitt Cancer Center. He currently practices at Florida Healthcare Specialists (an affiliate practice of Florida Cancer Specialists & Research Institute) and Cleveland Clinic Indian River Hospital. Dr. Davila is a leading physician researcher, having previously completed clinical studies on fibrosis, aging and nitric oxide, which were published in prestigious journals, such as Biology of Reproduction, Cardiovascular Research, Urology and British Journal of Urology. In 2004-5, Dr. Davila was awarded a Pfizer research grant about the “Effects of long-term therapy with Sildenafil on the histological and functional alterations of the aged corporal tissue; implications for reversal of corporal veno-occlusive dysfunction.” His most recent investigations have included the evaluation of robotic surgical techniques and pelvic floor ultrasonography for the correction of pelvic organ prolapses, with several publications in the Urology gold journal, Journal of Robotic Surgery and Journal of Obstetrics and Gynecology. Recently, Dr. Davila described a robotic and laparoscopic single site approach to apical prolapses using native tissue. He also presented a new robotic technique without mesh for pelvic organ prolapses at the European Association of Urology. An active member of the American Urology Association (AUA), European Association of Urology (EAU), Society of Robotic Surgery (SRS) and Latin-American Society of Pelvic Floor (ALAPP), he has a special interest in female pelvic medicine and reconstructive surgery; his most recent publications in the Journal of Robotic Surgery and Urology Gold Journal describes a new approach using ultrasonography assisted robotic surgery with pubocervical fascia plication and the description of the pubocervical fascia injury on 3D endovaginal ultrasound. He has presented multiple videos, podium and posters at the AUA, EAU, SRS and many international meetings.
Medical School:

Central University of Venezuela School of Medicine – Caracas, Venezuela


University of South Florida Health – Tampa, FL


Clinical Research Fellowship in Endourology – Cornell University/New York Presbyterian Hospital – New York, NY Postgraduate Research Fellowship in Urology – University of California/Los Angeles Center

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only